Vontobel Financial Products Ltd. Share Price

Certificat

RMARSV

CH1254574671

Market Closed - Bid/Ask 16:20:00 26/06/2024 BST After market 16:15:00
60.8 CHF +0.66% Intraday chart for Vontobel Financial Products Ltd. 60 -1.32%
3 months-35.18%
6 months-30.99%
Date Price Change
26/06/24 60.8 +0.66%
24/06/24 60.4 +1.34%

Delayed Quote Swiss Exchange

Last update June 26, 2024 at 04:20 pm

More quotes

Static data

Product typesonstige Zertifikate
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
RMARSV
ISINCH1254574671
Date issued 19/04/2023
Maturity 19/07/2024 (18 Days)
Parity 0.28 : 1
Emission price 100 CHF
Emission volume N/A
Settlement Barausgleich
Currency CHF

Technical Indicators

Highest since issue 99.6 CHF
Lowest since issue 59.3 CHF
Spread 18 CHF
Spread %2.96%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
250.1 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.18%
Consensus
  1. Stock Market
  2. Certificates
  3. RMARSV Certificat